These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 35498801)
1. Circulating FGF21 and GDF15 as Biomarkers for Screening, Diagnosis, and Severity Assessment of Primary Mitochondrial Disorders in Children. Li Y; Li S; Qiu Y; Zhou M; Chen M; Hu Y; Hong S; Jiang L; Guo Y Front Pediatr; 2022; 10():851534. PubMed ID: 35498801 [TBL] [Abstract][Full Text] [Related]
2. FGF21 outperforms GDF15 as a diagnostic biomarker of mitochondrial disease in children. Riley LG; Nafisinia M; Menezes MJ; Nambiar R; Williams A; Barnes EH; Selvanathan A; Lichkus K; Bratkovic D; Yaplito-Lee J; Bhattacharya K; Ellaway C; Kava M; Balasubramaniam S; Christodoulou J Mol Genet Metab; 2022 Jan; 135(1):63-71. PubMed ID: 34991945 [TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor 21 and grow differentiation factor 15 are sensitive biomarkers of mitochondrial diseases due to mitochondrial transfer-RNA mutations and mitochondrial DNA deletions. Formichi P; Cardone N; Taglia I; Cardaioli E; Salvatore S; Gerfo AL; Simoncini C; Montano V; Siciliano G; Mancuso M; Malandrini A; Federico A; Dotti MT Neurol Sci; 2020 Dec; 41(12):3653-3662. PubMed ID: 32504279 [TBL] [Abstract][Full Text] [Related]
4. Associations of FGF21 and GDF15 with mitochondrial dysfunction in children living with perinatally-acquired HIV: A cross-sectional evaluation of pediatric AIDS clinical trials group 219/219C. Gojanovich GS; Jacobson DL; Broadwell C; Karalius B; Kirmse B; Geffner ME; Jao J; Van Dyke RB; McFarland EJ; Silio M; Crain M; Gerschenson M; PLoS One; 2021; 16(12):e0261563. PubMed ID: 34972147 [TBL] [Abstract][Full Text] [Related]
5. FGF21 is a biomarker for mitochondrial translation and mtDNA maintenance disorders. Lehtonen JM; Forsström S; Bottani E; Viscomi C; Baris OR; Isoniemi H; Höckerstedt K; Österlund P; Hurme M; Jylhävä J; Leppä S; Markkula R; Heliö T; Mombelli G; Uusimaa J; Laaksonen R; Laaksovirta H; Auranen M; Zeviani M; Smeitink J; Wiesner RJ; Nakada K; Isohanni P; Suomalainen A Neurology; 2016 Nov; 87(22):2290-2299. PubMed ID: 27794108 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of serum biomarkers FGF21 and GDF15 compared to muscle sample in mitochondrial disease. Lehtonen JM; Auranen M; Darin N; Sofou K; Bindoff L; Hikmat O; Uusimaa J; Vieira P; Tulinius M; Lönnqvist T; de Coo IF; Suomalainen A; Isohanni P J Inherit Metab Dis; 2021 Mar; 44(2):469-480. PubMed ID: 32857451 [TBL] [Abstract][Full Text] [Related]
7. Protein biomarkers GDF15 and FGF21 to differentiate mitochondrial hepatopathies from other pediatric liver diseases. Van Hove JLK; Friederich MW; Strode DK; Van Hove RA; Miller KR; Sharma R; Shah H; Estrella J; Gabel L; Horslen S; Kohli R; Lovell MA; Miethke AG; Molleston JP; Romero R; Squires JE; Alonso EM; Guthery SL; Kamath BM; Loomes KM; Rosenthal P; Mysore KR; Cavallo LA; Valentino PL; Magee JC; Sundaram SS; Sokol RJ; Hepatol Commun; 2024 Jan; 8(1):. PubMed ID: 38180987 [TBL] [Abstract][Full Text] [Related]
8. Successful Glycemic Control Decreases the Elevated Serum FGF21 Level without Affecting Normal Serum GDF15 Levels in a Patient with Mitochondrial Diabetes. Murakami T; Ueba Y; Shinoto Y; Koga Y; Kaneda D; Hatoko T; Kato T; Yonemitsu S; Muro S; Oki S Tohoku J Exp Med; 2016 Jun; 239(2):89-94. PubMed ID: 27212224 [TBL] [Abstract][Full Text] [Related]
9. The fibroblast growth factor 21 concentration in children with mitochondrial disease does not depend on the disease stage, but rather on the disease genotype. Wesół-Kucharska D; Rokicki D; Greczan M; Kaczor M; Czekuć-Kryśkiewicz E; Piekutowska-Abramczuk D; Halat-Wolska P; Ciara E; Jaworski M; Jezela-Stanek A Pediatr Endocrinol Diabetes Metab; 2022; 28(2):141-151. PubMed ID: 35620925 [TBL] [Abstract][Full Text] [Related]
10. Heightened Serum Mitochondrial Biomarkers; FGF21 and NOS in Pediatric Anemia and a Negative Correlation between GDF15 and Serum Ferritin. Çakmak HM; Alpay M; Mahdızadeh C; Özalp SÇ; Türay S; Özde Ş; Kocabay K J Clin Med; 2024 Jul; 13(15):. PubMed ID: 39124668 [No Abstract] [Full Text] [Related]
11. Biomarkers and clinical rating scales for sodium pyruvate therapy in patients with mitochondrial disease. Koga Y; Povalko N; Inoue E; Nashiki K; Tanaka M Mitochondrion; 2019 Sep; 48():11-15. PubMed ID: 30738201 [TBL] [Abstract][Full Text] [Related]
12. FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study. Suomalainen A; Elo JM; Pietiläinen KH; Hakonen AH; Sevastianova K; Korpela M; Isohanni P; Marjavaara SK; Tyni T; Kiuru-Enari S; Pihko H; Darin N; Õunap K; Kluijtmans LA; Paetau A; Buzkova J; Bindoff LA; Annunen-Rasila J; Uusimaa J; Rissanen A; Yki-Järvinen H; Hirano M; Tulinius M; Smeitink J; Tyynismaa H Lancet Neurol; 2011 Sep; 10(9):806-18. PubMed ID: 21820356 [TBL] [Abstract][Full Text] [Related]
13. Altered GDF15 and FGF21 Levels in Response to Strenuous Exercise: A Study in Marathon Runners. Campderrós L; Sánchez-Infantes D; Villarroya J; Nescolarde L; Bayès-Genis A; Cereijo R; Roca E; Villarroya F Front Physiol; 2020; 11():550102. PubMed ID: 33329017 [TBL] [Abstract][Full Text] [Related]
14. Serum growth differentiation factor 15, but not lactate, is elevated in patients with Parkinson's disease. Miyaue N; Yabe H; Nagai M J Neurol Sci; 2020 Feb; 409():116616. PubMed ID: 31862518 [TBL] [Abstract][Full Text] [Related]
15. Growth Differentiation Factor 15 Is a Novel Diagnostic Biomarker of Mitochondrial Diseases. Ji X; Zhao L; Ji K; Zhao Y; Li W; Zhang R; Hou Y; Lu J; Yan C Mol Neurobiol; 2017 Dec; 54(10):8110-8116. PubMed ID: 27889897 [TBL] [Abstract][Full Text] [Related]
16. Cold exposure increases circulating fibroblast growth factor 21 in the evening in males and females. Hoekx CA; Martinez-Tellez B; Straat ME; Verkleij MMA; Kemmeren M; Kooijman S; Uhrbom M; de Jager SCA; Rensen PCN; Boon MR Endocr Connect; 2024 Jul; 13(7):. PubMed ID: 38781402 [TBL] [Abstract][Full Text] [Related]
17. A new diagnostic indication device of a biomarker growth differentiation factor 15 for mitochondrial diseases: From laboratory to automated inspection. Koga Y; Povalko N; Inoue E; Ishii A; Fujii K; Fujii T; Murayama K; Mogami Y; Hata I; Ikawa M; Fukami K; Fukumoto Y; Nomura M; Ichikawa K; Yoshida K J Inherit Metab Dis; 2021 Mar; 44(2):358-366. PubMed ID: 32965044 [TBL] [Abstract][Full Text] [Related]
18. Elevated serum growth differentiation factor 15 in multiple system atrophy patients: A case control study. Yue T; Lu H; Yao XM; Du X; Wang LL; Guo DD; Liu YM World J Clin Cases; 2020 Jun; 8(12):2473-2483. PubMed ID: 32607324 [TBL] [Abstract][Full Text] [Related]
19. Association between Circulating Growth Differentiation Factor 15 and Cirrhotic Primary Biliary Cholangitis. Li Z; Liu Y; Li X; Wu Y; Yang F; Mo Q; Chong Y Biomed Res Int; 2020; 2020():5162541. PubMed ID: 33178828 [TBL] [Abstract][Full Text] [Related]
20. The roles of FGF21 and GDF15 in mediating the mitochondrial integrated stress response. Jena J; García-Peña LM; Pereira RO Front Endocrinol (Lausanne); 2023; 14():1264530. PubMed ID: 37818094 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]